07 March 2022 : Retraction note
Retracted: The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib
DOI: 10.12659/MSM.936571
Med Sci Monit 2022; 28:e936571
Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
07 March 2022 : Retraction note
DOI: 10.12659/MSM.936571
Med Sci Monit 2022; 28:e936571
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.